Desjardins Global Asset Management Inc. Repligen Corp Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Repligen Corp stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 93 shares of RGEN stock, worth $13,501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93Holding current value
$13,501% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.04 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$741 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$246 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$224 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.06B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....